Muscular Dystrophies Clinical Trials

84 clinical trials for Muscular Dystrophies across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients — RECRUITING · PHASE2
• A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping — RECRUITING · PHASE3
• VirtualPark_Pediatric — RECRUITING · NA
• Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) — RECRUITING · NA
• Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia — RECRUITING · NA
• Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO) — RECRUITING · PHASE3
• ECoG BMI for Motor and Speech Control — RECRUITING · NA
• Muscle Health Measurements Using Electrical Impedance Myography — RECRUITING
• Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases — RECRUITING
• Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias — RECRUITING
• Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) — RECRUITING · NA
• Fear of Falling in Muscular Dystrophy — RECRUITING · NA
• Spanish Natural History Study for LAMA2 Muscular Dystrophy — RECRUITING
• Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping — OTHER
• Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) — COMPLETED · PHASE1
• Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) — ACTIVE_NOT_RECRUITING · PHASE2
• Defining Endpoints in Becker Muscular Dystrophy — ACTIVE_NOT_RECRUITING
• Genetic and Physical Study of Childhood Nerve and Muscle Disorders — ACTIVE_NOT_RECRUITING
• A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy — ACTIVE_NOT_RECRUITING · PHASE3
• A Multi-Dimensional Model of cAre and transItion for Patients With cOmplex RAre Diseases — ACTIVE_NOT_RECRUITING
• Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders — COMPLETED · NA
• Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders — COMPLETED · NA
• Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH) — COMPLETED · NA
• Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy — COMPLETED · PHASE3
• Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) — COMPLETED
• Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients — COMPLETED · PHASE2
• A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy — COMPLETED · PHASE2
• Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit — COMPLETED · NA
• COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis — ACTIVE_NOT_RECRUITING · NA
• NuroSleeve Powered Brace & Stimulation System to Restore Arm Function — ACTIVE_NOT_RECRUITING · NA
• Pilot Study of Cardiac MR in Patients With Muscular Dystrophy — COMPLETED
• Exercise Therapy for Patients with Muscle Dystrophies — COMPLETED · NA
• Cycle Exercise in Wheelchair Users With Muscular Dystrophy or Cerebral Palsy — COMPLETED · NA
• Dysferlinopathy Protein in Peripheral Blood Monocytes. — COMPLETED
• Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI] — OTHER · NA
• Exploring Accessible Beauty for Individuals With Upper Extremity Deficits — COMPLETED
• Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability — COMPLETED · NA
• [BrainConnexion] - Neurodevice Phase I Trial — OTHER · NA
• Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers — COMPLETED · PHASE1
• Biomarker Development in LGMD2i — COMPLETED
• SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis — WITHDRAWN · NA
• Schulze Muscular Dystrophy Ability Clinical Study — OTHER · NA
• Bullying in Youth With Muscular Dystrophy and Congenital Myopathies — COMPLETED
• Limb-Girdle Muscular Dystrophy Type 2I in Norway — OTHER
• A Study to Assess the Feasibility of Non-invasive Dried Blood Sampling — COMPLETED · PHASE1
• Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx — COMPLETED · NA
• Muscle Tissue Bank for Muscular Dystrophy — COMPLETED
• Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders — OTHER · NA
• Myotonic Dystrophy Type 1 Aerobic Exercise Study — COMPLETED · NA
• The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities — COMPLETED · NA

Refine this search